HIV Clinical Trials: Active Studies by Market and Country

• 24markets with active trials
• 1,142active studies on HIV Drugs
• 34of our places with active trials

Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026.

1. 1HIV Drugs1,142HIV Drugs: See them on ClinicalTrials.gov (opens in a new tab)
2. 2HIV Prevention278HIV Prevention: See them on ClinicalTrials.gov (opens in a new tab)
3. 3Pre-Exposure Prophylaxis (PrEP)84Pre-Exposure Prophylaxis (PrEP): See them on ClinicalTrials.gov (opens in a new tab)
4. 4HIV Treatment Adherence73HIV Treatment Adherence: See them on ClinicalTrials.gov (opens in a new tab)
5. 5Long-Acting HIV Treatment66Long-Acting HIV Treatment: See them on ClinicalTrials.gov (opens in a new tab)
6. 6Kaposi Sarcoma40Kaposi Sarcoma: See them on ClinicalTrials.gov (opens in a new tab)
7. 7HIV and Cervical Cancer Screening24HIV and Cervical Cancer Screening: See them on ClinicalTrials.gov (opens in a new tab)
8. 8HIV Among Men Who Have Sex With Men20HIV Among Men Who Have Sex With Men: See them on ClinicalTrials.gov (opens in a new tab)
9. 9HIV Drug Resistance19HIV Drug Resistance: See them on ClinicalTrials.gov (opens in a new tab)
10. 10HIV Self-Testing18HIV Self-Testing: See them on ClinicalTrials.gov (opens in a new tab)
11. 11Advanced HIV Disease15Advanced HIV Disease: See them on ClinicalTrials.gov (opens in a new tab)
12. 12Differentiated HIV Service Delivery12Differentiated HIV Service Delivery: See them on ClinicalTrials.gov (opens in a new tab)
13. 13HIV Testing Services10HIV Testing Services: See them on ClinicalTrials.gov (opens in a new tab)
14. 14HIV Prevention for Adolescent Girls and Young Women9HIV Prevention for Adolescent Girls and Young Women: See them on ClinicalTrials.gov (opens in a new tab)
15. 15Cryptococcal Meningitis5Cryptococcal Meningitis: See them on ClinicalTrials.gov (opens in a new tab)
16. 16Prevention of Mother-to-Child HIV Transmission5Prevention of Mother-to-Child HIV Transmission: See them on ClinicalTrials.gov (opens in a new tab)
17. 17HIV Among Key Populations4HIV Among Key Populations: See them on ClinicalTrials.gov (opens in a new tab)
18. 18HIV Among People Who Inject Drugs4HIV Among People Who Inject Drugs: See them on ClinicalTrials.gov (opens in a new tab)
19. 19Paediatric HIV4Paediatric HIV: See them on ClinicalTrials.gov (opens in a new tab)
20. 20Antiretroviral Therapy Coverage3Antiretroviral Therapy Coverage: See them on ClinicalTrials.gov (opens in a new tab)
21. 21Harm Reduction for People Who Use Drugs3Harm Reduction for People Who Use Drugs: See them on ClinicalTrials.gov (opens in a new tab)
22. 22HIV Among Sex Workers1HIV Among Sex Workers: See them on ClinicalTrials.gov (opens in a new tab)
23. 23HIV and TB Co-infection1HIV and TB Co-infection: See them on ClinicalTrials.gov (opens in a new tab)
24. 24HIV Viral Load Monitoring1HIV Viral Load Monitoring: See them on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026.

• Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...

  NCT05470491HIV Drugs

• Optimizing Medications and Lung Health in People With HIV Through Pharmacist-led Proactive E-Consults

  NCT07507435HIV Drugs

• Peer Behavioral Activation Utilization to Improve Substance Use and HIV Outcomes in People Receiving Long Acting Injectable-PrEP/ART (PUSH)

  NCT06501781HIV Drugs

• A Clinical Study of Alimatravir (MK-8527) in Transgender (Trans) and Gender Diverse Individuals on Gender-affirming Hormone Therapy and at Low Likelihood of Human Immunodeficiency Virus (HIV)-1 Exposure (MK-8527-018)

  NCT07850609HIV Prevention

• Using CBPR to Engage Hazardous Drinking Women in the HIV Prevention and Care Continuum

  NCT04090723HIV Prevention

• Linking Youth to Pre-Exposure Prophylaxis (PrEP) Services

  NCT07438041HIV Prevention

• Bringing Medicines for HIV Prevention to a Family Planning Clinic

  NCT06930508Pre-Exposure Prophylaxis (PrEP)

• Decentralized, Status Neutral, Stakeholder-engaged, Post-incarceration Intervention for People Living With and at Risk for HIV

  NCT07927673Pre-Exposure Prophylaxis (PrEP)

• Evaluating the Impact of Using the B-OK Bottles for HIV and ART Literacy in South Africa

  NCT07703891HIV Treatment Adherence

• Reducing Stigma and Building Employability Skills for Young People With HIV in Zambia

  NCT07732660HIV Treatment Adherence

• Outcomes of the PLHIV With Suboptimal Viral Suppression to Injectable Long-acting Antiretrovirals

  NCT06507059HIV Treatment Adherence

• A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

  NCT06694805Long-Acting HIV Treatment

• Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults

  NCT02951052Long-Acting HIV Treatment

• A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed

  NCT07650916Long-Acting HIV Treatment

• Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma

  NCT04799275Kaposi Sarcoma

• Pomalidomide Treatment in Patients With Kaposi Sarcoma

  NCT04577755Kaposi Sarcoma

• AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW)

  NCT06004011Kaposi Sarcoma

• C2001P-CS3: Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIV

  NCT07576842HIV and Cervical Cancer Screening

• C2001P-CS6: Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIV

  NCT07925307HIV and Cervical Cancer Screening

• Community, Home-based Education, Screening Services Strategy to Increase Cervical Cancer Control Access for HIV-Positive Women in Nigeria

  NCT06751030HIV and Cervical Cancer Screening

• A Chatbot to Reduce Chemsex and HIV-related Risk Behaviors Among Men Who Have Sex With Men

  NCT07472582HIV Among Men Who Have Sex With Men

• Evaluating the Effectiveness of a Mobile HIV Prevention App to Increase HIV and Sexually Transmitted Infections (STI) Testing and PrEP Initiation Among Rural Men Who Have Sex With Men

  NCT06205368HIV Among Men Who Have Sex With Men

• Adapting the ESTEEM Intervention to Improve Mental Health and PrEP Uptake Among Men at Risk of HIV

  NCT07792148HIV Among Men Who Have Sex With Men

• Investigating the Optimal Management of Dolutegravir Resistance

  NCT06762054HIV Drug Resistance

Source: ClinicalTrials.gov, Study records, newest update first. Retrieved 12 Nov 2026.

• People living with HIV (ages 15–49)
• New HIV infections
• Clinical trials: HIV

• Infectious diseases
• Diagnostics and lab testing
• Oncology
• Women's health
• Mental health
• Cardiovascular
• Diabetes